Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.14% |
| 2 | Financials | 4.52% |
| 3 | Industrials | 4.17% |
| 4 | Healthcare | 3.91% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
PUT
EOG Resources
EOG
$72.9B
| $31.6M | 0.01% |
377,700
+19,200
| +5% | +$1.41M |
|
1027
First Hawaiian
FHB
$3.43B
| $31.5M | 0.01% |
1,091,942
-857,134
| -44% | -$24.1M |
|
1028
CALL
General Dynamics
GD
$104B
| $31.5M | 0.01% |
178,500
-22,400
| -11% | -$4.02M |
|
1029
CALL
Bausch Health
BHC
$2.33B
| $31.3M | 0.01% |
1,047,500
+144,900
| +16% | +$3.77M |
|
1030
CALL
Neurocrine Biosciences
NBIX
$16.7B
| $31.3M | 0.01% |
291,500
+215,100
| +282% | +$22.5M |
|
1031
CALL
Capital One
COF
$136B
| $31.3M | 0.01% |
304,300
-125,500
| -29% | -$12.1M |
|
|
SAGE
1032
DELISTED
Sage Therapeutics
SAGE
| $31.2M | 0.01% |
432,222
+341,925
| +379% | +$42.1M |
|
1033
American Homes 4 Rent
AMH
$12.4B
| $31.2M | 0.01% |
1,190,034
-1,314,133
| -52% | -$34.3M |
|
1034
CALL
Estee Lauder
EL
$31.7B
| $31.2M | 0.01% |
151,000
-100
| -0.1% | -$19.4K |
|
1035
Fabrinet
FN
$19.2B
| $31.1M | 0.01% |
480,183
-26,194
| -5% | -$1.52M |
|
|
ARCH
1036
DELISTED
Arch Resources, Inc.
ARCH
| $31.1M | 0.01% |
433,948
+162,324
| +60% | +$12.4M |
|
1037
PUT
Sea Limited
SE
$69.8B
| $31.1M | 0.01% |
772,200
+206,300
| +36% | +$6.94M |
|
1038
PUT
BP
BP
$107B
| $31M | 0.01% |
820,200
-586,900
| -42% | -$22.3M |
|
1039
PUT
Vale
VALE
$63.4B
| $30.9M | 0.01% |
2,344,100
-122,800
| -5% | -$1.48M |
|
1040
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $30.9M | 0.01% |
+1,128,675
| New | +$29.7M |
|
1041
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.89B
| $30.9M | 0.01% |
304,570
-208,431
| -41% | -$21M |
|
|
CGC
1042
CALL
Canopy Growth
CGC
$391M
| $30.9M | 0.01% |
146,370
-990
| -0.7% | -$197K |
|
1043
CALL
Sherwin-Williams
SHW
$88.9B
| $30.8M | 0.01% |
158,400
-47,400
| -23% | -$9.04M |
|
|
QTS
1044
DELISTED
QTS REALTY TRUST, INC.
QTS
| $30.8M | 0.01% |
567,629
-329,538
| -37% | -$17.3M |
|
|
GRMN
1045
Garmin
GRMN
$59.1B
| $30.7M | 0.01% |
314,949
+258,501
| +458% | +$24.1M |
|
1046
CALL
Axsome Therapeutics
AXSM
$10.9B
| $30.7M | 0.01% |
297,000
+156,900
| +112% | +$6.34M |
|
|
COUP
1047
PUT
DELISTED
Coupa Software Incorporated
COUP
| $30.7M | 0.01% |
209,900
-34,800
| -14% | -$4.97M |
|
1048
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
| $30.7M | 0.01% |
288,400
-7,400
| -3% | -$778K |
|
1049
Vanguard Total Bond Market
BND
$158B
| $30.6M | 0.01% |
+365,320
| New | +$30.7M |
|
1050
PUT
Aflac
AFL
$63.5B
| $30.6M | 0.01% |
577,900
+331,400
| +134% | +$17.6M |
|
Similar funds
Citadel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,267 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.
Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.
- Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
- Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Citadel Advisors opened 1,220 new positions and closed 1,267 in Q4 2019.
- Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.